Physician profile
Robert Akey
NPI 1750927158
$11,178.16
in general payments reported to CMS, 2019-2025
32 companies · $2,132 in 2025
The $2,132 reported for 2025 was more than what 94% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,000 · 2022: $2,648 · 2023: $1,638 · 2024: $1,760 · 2025: $2,132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,530.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,530.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,020.50 | 2021-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Artisan |
| Abbvie INC. | $2,543.34 | 2022-2025 | Botox, Qulipta, Ubrelvy |
| Relievant Medsystems, INC. | $1,084.20 | 2022 | |
| Scilex Pharmaceuticals INC. | $398.53 | 2021-2025 | Ztlido |
| Saluda Medical Americas, INC. | $326.35 | 2023-2025 | Evoke, Evoke Scs |
| International Rehabilitative Sciences, INC | $268.00 | 2023-2025 | Rs 4i Plus Sequential Stimulator, Rs-4i Plus With Intersperse |
| Nevro Corp. | $265.32 | 2021-2022 | |
| Pfizer INC. | $202.92 | 2021-2025 | |
| Spr Therapeutics, INC | $198.14 | 2023-2025 | Sprint Pns System |
| Lilly USA, LLC | $190.97 | 2024-2025 | Emgality |
| Vertos Medical, INC. | $184.67 | 2022-2024 | Mild Device Kit |
| Nalu Medical, INC. | $184.15 | 2025 | Nalu Neurostimulation System |
| Vertex Pharmaceuticals Incorporated | $183.69 | 2024-2025 | |
| Collegium Pharmaceutical, INC. | $156.00 | 2022-2025 | Belbuca, Nucynta |
| Si-Bone, INC. | $152.09 | 2025 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $139.33 | 2021-2024 | Tirosint, Licart, Tirosint |
| Biohaven Pharmaceutical Holding Company Ltd. | $130.52 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $89.32 | 2023 | Seglentis |
| Azurity Pharmaceuticals, INC. | $84.60 | 2023 | Horizant |
| Teva Pharmaceuticals USA, INC. | $73.53 | 2021-2022 | |
| Abbott Laboratories | $54.43 | 2022 | |
| Arbor Pharmaceuticals, INC. | $39.43 | 2021-2022 | |
| Ipsen Biopharmaceuticals, INC | $34.89 | 2024 | Dysport |
| Grt US Holding, INC. | $28.90 | 2022 | |
| Averitas Pharma INC. | $22.95 | 2025 | Qutenza |
| Lundbeck LLC | $22.93 | 2025 | Vyepti |
| Pacira Pharmaceuticals Incorporated | $21.47 | 2024 | Exparel, Zilretta, Iovera |
| Indivior INC. | $17.55 | 2021 | |
| Horizon Therapeutics Plc | $17.18 | 2021 | |
| Bioventus LLC | $15.73 | 2025 | Supartz Fx Sodium Hyaluronate |
| Fidia Pharma USA INC. | $13.90 | 2021 | |
| Avanos Medical | $12.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Akey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.